title: Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.
abstract: Non-small-cell lung cancer (NSCLC) is a very common disease in the elderly population and its incidence in this particular population is expected to increase further, because of the ageing of the Western population. Despite this, limited data are available for the treatment of these patients and, therefore, the development of evidence-based treatment recommendations is challenging. In 2010, European Organization for Research and Treatment of Cancer (EORTC) took an initiative in collaboration with International Society of Geriatric Oncology (SIOG) and created an experts panel that provided an experts' opinion consensus paper for the management of elderly NSCLC patients. Since this publication, important new data are available and EORTC and SIOG recommended to update the 2010 recommendations. Besides recommendations for surgery, adjuvant chemotherapy and radiotherapy, treatment of locally advanced and metastatic disease, recommendations were expanded, to include data on patient preferences and geriatric assessment.
authors.affiliation: Medical Department, European Organization for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: athanasios.pallis@eortc.be.
authors.forename: A G
authors.initials: AG
authors.lastname: Pallis
authors.affiliation: Division of Medical Oncology, 'S.G. Moscati' Hospital-Avellino, Avellino, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Gridelli
authors.affiliation: Department of Internal Medicine II, Jena University Hospital, Jena, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Wedding
authors.affiliation: The Christie NHS Foundation Trust, Manchester, UK.
authors.forename: C
authors.initials: C
authors.lastname: Faivre-Finn
authors.affiliation: Lung Cancer Early Detection Unit, Division of Thoracic Surgery, European Institute of Oncology, Milano, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Veronesi
authors.affiliation: Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
authors.forename: M
authors.initials: M
authors.lastname: Jaklitsch
authors.affiliation: Department of Medical Oncology, S. Paolo Hospital, Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Luciani
authors.affiliation: The Royal Marsden NHS Foundation, Surrey, UK.
authors.forename: M
authors.initials: M
authors.lastname: O'Brien
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D011379:Prognosis
keywords: EORTC; NSCLC; SIOG; age; elderly